CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Staying motivated to save money can be challenging. Explore effective strategies to keep your savings goals in sight and stay committed.
18,632 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
In a pivotal moment, kevin warsh debuts chair at the Federal Reserve, with policymakers keeping the federal funds rat...
Mortgage originations in 2026 are shifting from chasing lower rates to serving life events. Relocation, growing famil...
The supreme court rules against Trump's bid to fire Lisa Cook at the Federal Reserve, keeping her in place as the cas...
A 25-year-old has amassed a $500k stock portfolio, 13 rental properties, and about $10,000 in monthly gross income wh...
GCC debt markets climbed again this week, with six new issues totaling about $6.8 billion and spreads tightening as i...
Memory markets have swung on supply timing. This article breaks down what micron's says this when means for pricing p...
As markets wobble, some Americans are eyeing a Greek island retirement as a cost-conscious path. This piece breaks do...
As Medicare costs rise in 2026, a diversified income plan offers a path to cover health coverage indefinitely. Expert...
Palantir chief executive officer Alex Karp charges that frontier AI models are siphoning value from enterprises. The ...
SpaceX captures headlines with bold tech and presumed multi-bagger upside. Still, the stock question isn’t simple. Th...
A $900,000 inherited 401(k) faces the SECURE Act’s 10-year rule, with recent IRS guidance adding complexity for heirs...